“The promises of Treg autoimmune therapy – all in one hand” – PolTREG publishes new investor slide deck

2023-12-22

Download Investor Presentation here:

See other news

2025-01-09

PolTREG obtains Japanese patent for intrathecal PTG-007 therapy in multiple sclerosis

See

2024-11-20

Join us for the PolTREG Q3 2024 financial results webinar!

See

2024-11-14

PolTREG received a new patent from China for anti-gen specific Tregs cellular therapy

See

2024-10-24

PolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetes

See

2024-09-26

PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune diseases

See

2024-09-16

China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis

See

2024-09-11

Join us for the PolTREG H1 2024 financial results webinar!

See

2024-09-09

PolTREG Treg cell therapy for patients with type-1 diabetes shows long-term clinical remission and insulin independence

See